18 employees
Biosion is a biotech company focused on the development of biologics to treat resistant, relapsed, residual immune, and oncologic diseases.
2017
$31M
from 3 investors over 3 rounds
Biosion raised undisclosed on December 28, 2022
Investors: GF Xinde Investment Management Co.,Ltd and 毅达资本
Biosion raised $31M on December 9, 2021
Investors: 3E Bioventures Capital